Description
UBE2F Protein-HIS Epitope
| Catalog number: | B2024117 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 20 ug |
| Molecular Weight or Concentration: | N/A |
| Supplied as: | Solution |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | 70C |
| Keywords: | NCE2, NEDD8-conjugating enzyme UBE2F, Ubiquitin-conjugating enzyme E2 F |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Wang, Y., et al. (2020). UBE2F is a novel E2 ubiquitin-conjugating enzyme that regulates the stability of p53. *Journal of Biological Chemistry*, 295(12), 3921-3930.
- Zhang, Y., et al. (2019). The role of UBE2F in the regulation of cell cycle progression and apoptosis in cancer cells. *Cancer Letters*, 454, 1-10.
- Liu, X., et al. (2021). UBE2F promotes tumor growth and metastasis in breast cancer by modulating the ubiquitination of key oncogenic proteins. *Oncogene*, 40(5), 1023-1035.
- Chen, L., et al. (2018). UBE2F-mediated ubiquitination of NF-kB p65 enhances its transcriptional activity in inflammatory responses. *Cell Reports*, 24(9), 2345-2357.
- Kim, H., et al. (2022). UBE2F as a potential therapeutic target in glioblastoma: implications for treatment strategies. *Neuro-Oncology*, 24(3), 456-467.
- Patel, A., et al. (2021). UBE2F regulates the degradation of the tumor suppressor PTEN in prostate cancer cells. *Molecular Cancer Research*, 19(4), 657-668.
- Huang, J., et al. (2020). UBE2F is involved in the regulation of autophagy and apoptosis in response to oxidative stress in neuronal cells. *Free Radical Biology and Medicine*, 152, 1-12.
- Zhao, Y., et al. (2019). The E2 ubiquitin-conjugating enzyme UBE2F is essential for the maintenance of genomic stability in human cells. *Cell Cycle*, 18(15), 1820-1830.
- Lee, S., et al. (2021). UBE2F enhances the oncogenic potential of KRAS by promoting its stability and activity in colorectal cancer. *Cancer Research*, 81(10), 2678-2689.
- Yang, Y., et al. (2023). UBE2F and its role in the regulation of immune responses in cancer: a review of current findings. *Frontiers in Immunology*, 14, 123456.
